Enovis Balance Sheet Health
Financial Health criteria checks 3/6
Enovis has a total shareholder equity of $3.3B and total debt of $1.3B, which brings its debt-to-equity ratio to 40.4%. Its total assets and total liabilities are $5.5B and $2.2B respectively.
Key information
40.4%
Debt to equity ratio
US$1.34b
Debt
| Interest coverage ratio | n/a |
| Cash | US$66.27m |
| Equity | US$3.31b |
| Total liabilities | US$2.17b |
| Total assets | US$5.48b |
Recent financial health updates
Is Enovis (NYSE:ENOV) Using Too Much Debt?
Jan 14
Is Enovis (NYSE:ENOV) A Risky Investment?
Sep 22We Think Enovis (NYSE:ENOV) Has A Fair Chunk Of Debt
Jun 20Is Enovis (NYSE:ENOV) A Risky Investment?
Feb 22Is Enovis (NYSE:ENOV) A Risky Investment?
Oct 19Here's Why Enovis (NYSE:ENOV) Can Manage Its Debt Responsibly
Jul 05Recent updates
Enovis: Solid Growth, But Unstable Financial Footing
May 05Enovis Corporation (NYSE:ENOV) Might Not Be As Mispriced As It Looks
Apr 22Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)
Feb 12Is Enovis (NYSE:ENOV) Using Too Much Debt?
Jan 14Investors Holding Back On Enovis Corporation (NYSE:ENOV)
Dec 18Calculating The Fair Value Of Enovis Corporation (NYSE:ENOV)
Nov 05Enovis Making Good Choices, But Not Seeing The Rewards
Sep 27Is Enovis (NYSE:ENOV) A Risky Investment?
Sep 22Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)
Aug 03Enovis Corporation: Things Are Looking Good As Guidance Is Raised
Jul 18We Think Enovis (NYSE:ENOV) Has A Fair Chunk Of Debt
Jun 20Enovis Corporation Q4 2022 Earnings Preview
Feb 22Is Enovis (NYSE:ENOV) A Risky Investment?
Feb 22Is Enovis Corporation (NYSE:ENOV) Worth US$60.5 Based On Its Intrinsic Value?
Jan 25Enovis Corporation reports Q3 earnings beat; updates FY22 guidance
Nov 02Is Enovis (NYSE:ENOV) A Risky Investment?
Oct 19Is Enovis Corporation (NYSE:ENOV) Trading At A 27% Discount?
Sep 14Enovis launches augmented reality system ARVIS for use in hip, knee surgery
Jul 19Here's Why Enovis (NYSE:ENOV) Can Manage Its Debt Responsibly
Jul 05Enovis announces CFO transition
Jun 30Enovis: Medtech Leftover Of Colfax With Some To Prove
May 23As The Colfax Chapter Ends, Both ESAB And Enovis Have Something To Prove
Apr 05Is Colfax (NYSE:CFX) Using Too Much Debt?
Feb 20With EPS Growth And More, Colfax (NYSE:CFX) Is Interesting
Jan 05Colfax - Thoughts Ahead Of The Spin-Off
Jan 04Colfax Corporation (NYSE:CFX) Shares Could Be 32% Below Their Intrinsic Value Estimate
Dec 21Is Colfax (NYSE:CFX) Using Too Much Debt?
Nov 21Do Colfax's (NYSE:CFX) Earnings Warrant Your Attention?
Sep 30Is There An Opportunity With Colfax Corporation's (NYSE:CFX) 29% Undervaluation?
Sep 13Colfax: Setup Turns Compelling Heading Into The Upcoming Separation Event
Aug 15Financial Position Analysis
Short Term Liabilities: ENOV's short term assets ($1.2B) exceed its short term liabilities ($549.1M).
Long Term Liabilities: ENOV's short term assets ($1.2B) do not cover its long term liabilities ($1.6B).
Debt to Equity History and Analysis
Debt Level: ENOV's net debt to equity ratio (38.4%) is considered satisfactory.
Reducing Debt: ENOV's debt to equity ratio has reduced from 111.5% to 40.4% over the past 5 years.
Debt Coverage: ENOV's debt is not well covered by operating cash flow (6.8%).
Interest Coverage: Insufficient data to determine if ENOV's interest payments on its debt are well covered by EBIT.